Ide-cel versus standard regimens in patients with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): a KarMMa-3 analysis in the modified intention to-treat (mITT) population

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览5
暂无评分
关键词
refractory multiple myeloma,ide-cel,triple-class,to-treat
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要